Tanshinone IIA inhibits epithelial-mesenchymal transition in ovarian cancer by promoting NR3C2 transcriptional activation of ING1

Xiaoqin Wang, Duoyi Zhang, Tingting Wang, Xin Li, Jing Zhang · 2026

Read Tanshinone IIA inhibits epithelial-mesenchymal transition in ovarian cancer by promoting NR3C2 transcriptional activation of ING1 by Xiaoqin Wang, Duoyi Zhang, Tingting Wang, Xin Li, Jing Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13197640.txt.

Description

Xiaoqin Wang and co-authors test a plant compound against ovarian cancer in a 2026 lab study. Ovarian cancer is among the deadliest cancers of the female reproductive system. The compound, Tanshinone IIA, comes from a traditional medicinal herb. The team studied how it affects a process called EMT, in which cancer cells loosen and gain the ability to spread.

The compound slowed cancer cell growth, movement, and invasion, and it blocked the spread program in a dose based way. It worked by raising levels of a receptor protein, which switches on a growth blocking gene. When the receptor was knocked down, the compound lost much of its force. Turning the gene back on rescued the effect. Patient data backed the chain: low levels of both proteins tracked with advanced stage and worse survival.

Catalog record

CREATORXiaoqin Wang, Duoyi Zhang, Tingting Wang, Xin Li, Jing Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13197640

Browse the full library · About the Tower of Babel